Skip to main content
Isomer
  1. Home
  2. About drugs
  3. NDF A-Z listing
  4. ${Monograph Name}
${Monograph Name} - First character of monograph name

${Monograph Name}

Subsidy Information and Financing Scheme

${Subsidy Information and Financing Scheme_1 - 15} - Split '~' [0], add more tags if applicable

Drug Guidance

${Drug Guidance for Subsidy_1 - 15} - Yes if exist, No if not

Post-marketing information

${Post-marketing Information_1} - Yes if exist, No if not

Summary of Biologics

${Monograph Name} - Yes if # is at the end of Monograph name

Information about ${Monograph Name}

General information

Subsidy Information and Financing Scheme

[${Subsidy Information and Financing Scheme_1 - 15} - split '~' [0]] ${Subsidy Information and Financing Scheme_1 - 15} - split '|' [0]

  1. ${Subsidy Information and Financing Scheme_1 - 15} - remaining from ^, add hardBreak if
    is present

Legend

This section shows the following:

As this website is updated monthly, please refer to MOH List of Subsidised Drugs, MOH Subsidised Vaccine List or MediShield Life Cancer Drug List for the most updated information.

Legend list

Indicator

Legend

SDL

Standard Drug List

MAF

Medical Assistance Fund

SVL

Subsidised Vaccine List

MSHL

Cancer Drug and Clinical Indication listed in the MediShield Life Cancer Drug List

Drug Guidance for Subsidy

${Drug Guidance for Subsidy_1 - 15}

${Guidance Recommendations_1 - 15}

Legend

This section displays recommendation from the MOH Drug Advisory Committee for subsidy and appropriate use of the drug as extracted from the Agency for Care Effectiveness (ACE) Drug Guidances. As this website is updated monthly, please refer to the ACE website for the most updated information.

Legend list

Indicator

Legend

R

Recommended for subsidy

NR

Not recommended for subsidy

General Availability in Public Healthcare Institution

Note:

General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.

Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Drug availability

Formulation

Public Healthcare Institution

${General Availability in Public Healthcare Institutions_1 - split '|' [0]}

${General Availability in Public Healthcare Institutions_1 - remaining from split}

${General Availability in Public Healthcare Institutions_2 - 15 - split '|' [0]}

${General Availability in Public Healthcare Institutions_2 - 15 - remaining from split}

Registered Product(s) Information

Clinical and product info

Clinical info

Product Info

Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch.

The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice.

Information available here are product details as registered with the HSA. As this website is updated

monthly, please refer to HSA Infosearch for the most updated product information.

${Route of Administration}

  • ${Product Name} [${Licence number (SIN number)}]

  • VERZENIO FILM-COATED TABLET 150MG [SIN15790P]*

  • VERZENIO FILM-COATED TABLET 50MG [SIN15788P]

  • YULAREB FILM-COATED TABLET 100MG [SIN16575P]

  • YULAREB FILM-COATED TABLET 150MG [SIN16576P]

  • YULAREB FILM-COATED TABLET 50MG [SIN16574P]

* The following products do not have any clinical information available (example)

Back to top